午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Cyclobenzaprine USP Related Compound A
Cyclobenzaprine USP Related Compound A
  • Cyclobenzaprine USP Related Compound A
  • Cyclobenzaprine USP Related Compound A
  • Cyclobenzaprine USP Related Compound A
  • Cyclobenzaprine USP Related Compound A
  • Cyclobenzaprine USP Related Compound A

Cyclobenzaprine USP Related Compound A NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-06-18

Product Details

Product Name: Cyclobenzaprine USP Related Compound A CAS No.: 18029-54-4
Min. Order: 10mg Purity: 99%+ HPLC
Supply Ability: 1000 Release date: 2025/06/18

Cyclobenzaprine USP Related Compound A; 18029-54-4

Article illustration


Product Information

  • Product Code:C140001

  • English Name:Cyclobenzaprine USP Related Compound A

  • English Alias:5-(3-(dimethylamino)propyl)-5H-dibenzo[a,d][7]annulen-5-ol

  • CAS No.:18029-54-4

  • Molecular Formula:C??H??NO

  • Molecular Weight:293.40

Advantages

  • High-Purity Reference Standard:Confirmed by HPLC (≥99.0%), NMR (1H, 13C), HRMS, and elemental analysis, compliant with USP standards, suitable for Cyclobenzaprine impurity analysis and quality control.

  • Stability Assurance:Stable for 36 months at -20℃ under light-protected, sealed storage; degradation rate <0.3% in methanol-water mixture within 6 months.

Applications

  • USP Compliance Testing:Used for UPLC-MS/MS detection of USP Related Compound A in Cyclobenzaprine API and formulations, controlling content to meet USP pharmacopoeia standards (single impurity limit ≤0.1%).

  • Process Optimization Research:Monitors impurity formation during Cyclobenzaprine synthesis, reducing generation by >40% by adjusting cyclization temperature (e.g., 80-90℃) and reaction time.

  • Method Validation:Serves as a USP reference standard for developing impurity detection methods, verifying UPLC resolution (≥3.0) and LOD (0.01 ng/mL).

Background Description

Cyclobenzaprine, a skeletal muscle relaxant, is used to relieve muscle spasms. USP Related Compound A, as a process-related impurity of Cyclobenzaprine, may originate from hydroxylation side reactions during dibenzocycloheptene ring synthesis. Its hydroxyl and dimethylamino groups may affect drug stability and efficacy. Due to specific control requirements in the USP, studying this impurity is crucial for ensuring Cyclobenzaprine quality.

Research Status

  • Detection Technology:UPLC-MS/MS with C18 column (1.7μm) and 0.1% formic acid-acetonitrile gradient elution achieves separation within 6 minutes, with LOD of 0.005 ng/mL meeting USP pharmacopoeia trace analysis requirements.

  • Formation Mechanism:Formed by hydration of 5-(3-(dimethylamino)propyl)-5H-dibenzo[a,d][7]annulene under acidic conditions (e.g., acetic acid/water system); optimizing reaction pH and solvent polarity inhibits side reactions.

  • Safety Evaluation:In vitro cytotoxicity shows IC?? of 195.3 μM against C2C12 muscle cells (Cyclobenzaprine IC??=12.6 μM), with lower toxicity than the main drug but requiring strict content control. Long-term stability testing is ongoing to monitor degradation under different humidity, light, and temperature conditions.

WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com


NOTE!

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com


NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery! 





Company Profile Introduction

1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability. 2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs. 3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects. 4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes. 5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/10mg
VIP2Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2025-02-06
$40.00/1kg
VIP6Y
Hebei Yanxi Chemical Co., Ltd.
2023-09-22
$0.00/5mg
VIP1Y
Guangzhou Tosun Pharmaceutical Ltd
2025-02-18
$9.80/1KG
VIP6Y
Career Henan Chemical Co
2020-01-03
INQUIRY